5-(1-methyl-hexyl)-benzene-1,3-diol | 22168-68-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 5-(1-methyl-hexyl)-benzene-1,3-diol
• 英文别名: 5-(1-methyl-hexyl)-resorcinol；5-(1-Methyl-hexyl)-resorcin；(+/-)-3.5-Dihydroxy-1-(1-methyl-hexyl)-benzol；5-(2-heptyl)resorcinol；5-heptan-2-ylbenzene-1,3-diol
• CAS: 22168-68-9
• 化学式: C₁₃H₂₀O₂
• 分子量: 208.301
• InChiKey: VAJVWSMJFZNVGT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-(1-methyl-hexyl)-benzene-1,3-diol 在 硫酸 、 三氯氧磷 作用下， 生成 2,5,5-trimethyl-8-(1-methyl-hexyl)-1,3,4,5-tetrahydro-2H-chromeno[4,3-c]pyridin-10-ol
  参考文献：
  名称：

  Drugs derived from cannabinoids. 1. Nitrogen analogs, benzopyranopyridines and benzopyranopyrroles

  摘要：

  Various nitrogen analogs of delta6a,10a-tetrahydrocannabinol were synthesized by a general procedure described in an earlier communication. Minimum effective doses (MED50's) and lethal doses (LD50's) were determined by a modified Irwin mouse screen after iv administration of compounds in PEG 200. The most potent compounds were the propargyl (5t), allyl (5m), and chloroallyl (5o-q) derivatives. Overt behavioral effects (CNS depression, static ataxia, and hypersensitivity) of 5t and Roger Adams' carbocyclic analog (III) were found to be similar in the mouse, cat, dog, and monkey. Dichloroisoproterenol prevented and reversed many of the depressant effects of both III and 5t but had no effect on the ataxia produced by these compounds. In antinociceptive tests, 5t was active in the phenylquinone and Eddy hot-plate tests but was inactive in the tail-flick test.

  DOI：

  10.1021/jm00226a001
• 作为产物：
  描述：

  2-(3.5-Dimethoxyphenyl)-2-hepten 在 乙醇 、 氢溴酸 、 镍 、 溶剂黄146 作用下， 生成 5-(1-methyl-hexyl)-benzene-1,3-diol
  参考文献：
  名称：

  Tetrahydrocannabinol Homologs with a s-Alkyl Group in the 3-Position. XVI¹

  摘要：

  DOI：

  10.1021/ja01225a040

文献信息

• MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME
  申请人：TABATA Masayoshi

  公开号：US20110224343A1

  公开（公告）日：2011-09-15

  The present invention provides a modifier for aromatic polyesters which enhances the melt fluidity of aromatic polyesters without a significant decrease in the heat resistance of the aromatic polyesters, and an aromatic polyester resin composition including the modifier for aromatic polyesters. The present invention relates to a modifier for aromatic polyesters comprising polyhydric phenol residues and residues of aromatic polycarboxylic acid, acid halide or acid anhydride thereof, and the modifier comprises a material having a structure composed of a first residue selected from the group consisting of divalent residues represented by Formula (I): —Ar—W 1 x —Ar— and by Formula (II): —Ar—, the first residues being bonded to two identical or different second residues selected from the group consisting of monovalent residues represented by Formula (III): and monovalent residues represented by Formula (IV): —O—C(O)—R 7 —.

  本发明提供了一种用于芳香族聚酯的改性剂，可以增强芳香族聚酯的熔融流动性，而不明显降低芳香族聚酯的耐热性，以及包括该改性剂的芳香族聚酯树脂组合物。本发明涉及一种用于芳香族聚酯的改性剂，包括多羟基酚残基和芳香族多羧酸、酸卤或其酸酐残基，该改性剂包括具有以下结构的材料：第一残基，选择自由式(I)所代表的二价残基：—Ar—W1x—Ar—和自由式(II)所代表的：—Ar—，第一残基与选择自由式(III)所代表的单价残基：和自由式(IV)所代表的单价残基：—O—C(O)—R7—的两个相同或不同的第二残基结合。
• Anesthesia methods using benzopyrans and esters thereof as
  申请人：Abbott Laboratories

  公开号：US04025630A1

  公开（公告）日：1977-05-24

  Improved anesthesia methods comprising pretreating a patient to be anesthetized with a benzopyran of formula I ##STR1## wherein, in the C ring, X is NR.sub.1, S, CH.sub.2 or ##STR2## R.sub.1 is hydrogen, loweralkyl, loweralkenyl, loweralkynyl, loweralkanoyl, cycloalkyloweralkyl, cycloalkylloweralkanoyl, cycloalkyl, haloloweralkyl, haloloweralkenyl, phenylloweralkyl, phenyloweralkenyl or phenyloweralkylnyl; m is an integer from 0 to 3, n is an integer from 0 to 3 and n + m = 2 or 3; or the C ring is quinuclidine ring ##STR3## R.sub.2 is loweralkyl; R.sub.3 is hydrogen or ##STR4## wherein Y is a straight or branched chain alkylene group having from one to eight carbon atoms, a is an integer from 1 to 4, b is an integer from 1 to 4, Z is CH.sub.2, O, S or NR.sub.6, R.sub.6 being hydrogen or loweralkyl, with the limitation that when Z is O, S or NR.sub.5, the sum of a and b is 3 or 4, and R.sub.5 is hydrogen or loweralkyl; R.sub.4 is C.sub.1 -C.sub.20 straight or branched chain alkyl, cycloalkyl, or ##STR5## wherein Y is a straight or branched chain alkylene group having from one to ten carbon atoms, and each R.sub.7, R.sub.8 and R.sub.9 are the same or different members of the group consisting of hydrogen, halo, trifluoromethyl or loweralkyl; and the pharmaceutically acceptable salts thereof, with the limitation that when X is ##STR6## m = 2 and n = 2, R.sub.3 cannot be hydrogen.

  改进的麻醉方法包括使用化学式I的苯并吡喃预处理待麻醉的患者 其中，在C环中，X是NR.sub.1，S，CH.sub.2或##STR2## R.sub.1是氢，低烷基，低烯基，低炔基，低酰基，环烷基低烷基，环烷基低酰基，环烷基，卤代低烷基，卤代低烯基，苯基低烷基，苯基低烯基或苯基低烷基; m是0到3的整数，n是0到3的整数，n + m = 2或3;或C环是喹啉环##STR3## R.sub.2是低烷基; R.sub.3是氢或##STR4##其中Y是具有1至8个碳原子的直链或支链烷基基团，a是1到4的整数，b是1到4的整数，Z是CH.sub.2，O，S或NR.sub.6，R.sub.6为氢或低烷基，限制是当Z为O，S或NR.sub.5时，a和b的总和为3或4，R.sub.5为氢或低烷基; R.sub.4是C.sub.1-C.sub.20直链或支链烷基，环烷基，或##STR5##其中Y是具有1到10个碳原子的直链或支链烷基基团，每个R.sub.7，R.sub.8和R.sub.9是氢，卤素，三氟甲基或低烷基的相同或不同成员;及其药用盐，限制是当X为##STR6##时，m = 2，n = 2，R.sub.3不能是氢。
• CB2-selective cannabinoid derivatives
  申请人：Martin R. Billy

  公开号：US20060183922A1

  公开（公告）日：2006-08-17

  Cannabinoid derivatives that exhibit specificity for the CB 2 cannabinoid receptor are provided. The analogues are tetrahydrocannabinols and hydroxyhexahydrocannabinols, and are useful for the treatment of pain, inflammation, and cancer.

  提供了具有对CB2大麻素受体特异性的大麻素衍生物。这些类似物是四氢大麻酚和羟基六氢大麻酚，可用于治疗疼痛、炎症和癌症。
• Intermediates for the preparation of thienobenzopyrans and
  申请人：Arthur D. Little, Inc.

  公开号：US03940421A1

  公开（公告）日：1976-02-24

  Novel thienobenzopyrans and thiopyranobenzopyrans represented by the formula ##SPC1## Wherein m and n are each 0, 1, 2 or 3 and m + n is 2 or 3; R.sub.1 is loweralkyl; R.sub.2 is alkyl or cycloalkylloweralkyl and R.sub.3 is hydrogen, loweralkyl, loweralkanoyl, carbamyl, N-loweralkylcarbamyl, N,N-diloweralkylcarbamyl, phosphonyl, hemisuccinate or an ester of another such acid, phosphate, dialkylaminoalkyl of the structure ##EQU1## or acid addition salt thereof, or dialkylaminoalkylanoyl of the structure ##EQU2## or acid addition salt thereof, wherein x is 1 through 6 and R.sub.4 and R.sub.5 are loweralkyl; the loweralkyl groups containing from 1 through 6 carbon atoms, the alkyl groups containing from 1 through 20 carbon atoms and the cycloalkyl groups containing from 3 through 8 ring carbon atoms. Novel intermediates for the synthesis of these compounds are also disclosed as well as methods for making the compounds.

  该专利涉及一种新型的噻吩并苯并吡喃和噻吩并苯并噻吩喹啉类化合物，其化学式为##SPC1##其中m和n分别为0、1、2或3，且m+n为2或3；R.sub.1为低碳基；R.sub.2为烷基或环烷基低碳基，R.sub.3为氢、低碳基、低碳酰基、氨基甲酰基、N-低碳基氨基甲酰基、N,N-二低碳基氨基甲酰基、磷酸酯、半琥珀酸或另一种酸的酯、磷酸酯、结构为##EQU1##的二烷基氨基烷基或其酸加成盐，或结构为##EQU2##的二烷基氨基烷酰基或其酸加成盐，其中x为1到6，R.sub.4和R.sub.5为低碳基；低碳基含1到6个碳原子，烷基含1到20个碳原子，环烷基含3到8个环碳原子。该专利还公开了合成这些化合物的新型中间体以及制备这些化合物的方法。
• AROMATIC POLYESTER
  申请人：Muroran Institute of Technology

  公开号：EP2479203A1

  公开（公告）日：2012-07-25

  The present invention provides an aromatic polyester which is substantially free from the occurrence of coloration and retains significantly high transparency even after being thermally processed at high temperature and which has high flowability. The aromatic polyester contains a polyhydric phenol residue and a residue of any one of aromatic polycarboxylic acid, halide thereof, and anhydride thereof, and terminals of the aromatic polyester have a structure represented by the formula -C(O)-R. The aromatic polyester has an end-capping rate of 90% or higher and a weight average molecular weight (Mw) ranging from 3,000 to 1,000,000.

  本发明提供了一种芳香族聚酯，该聚酯基本上不会发生着色，即使在高温热加工后仍能保持明显的高透明度，并且具有高流动性。芳香族聚酯含有多羟基苯酚残留物和芳香族多羧酸、其卤化物和其酸酐中任意一种的残留物，芳香族聚酯的端基具有式 -C(O)-R 所代表的结构。芳香族聚酯的端盖率为 90% 或更高，重量平均分子量（Mw）为 3,000 至 1,000,000 之间。